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1712calculated the cumulative paper count as a proportion
of the total number of the journal’s papers (Xk) and
the cumulative citation count as a proportion of the
total cumulative citations of all papers within the
journal (Yk). We then estimated the Gini coefﬁcient
using the equation for approximating Gini using
discrete data points (1,5):
G1 ¼ 1
Xn
k¼ 1
ðXk  Xk1ÞðYk þ Yk1Þ
We used linear regression to quantitatively assess
the relationship between the Gini coefﬁcient and
the logarithmically-transformed IF. The log trans-
formation was done to satisfy the homoscedasticity
assumption for the linear regression. To determine
the effect of guidelines, statements, and statistical
reports on citation distributions, we excluded them
from the top 3 IF journals and recalculated their
Gini coefﬁcients. All analyses were conducted using
Stata version 12.0 (Stata Corp Inc., College Station,
Texas).
There were 129 journals included in our analysis.
IFs of journals ranged from 0.2 to 15.2, with a median
of 2.4 (interquartile range: 1.2 to 3.7). The Gini
coefﬁcients for cardiovascular journals ranged from
0.36 to 0.82, with a median of 0.54 (interquartile
range: 0.50 to 0.61).
There was an inverse relationship between the Gini
coefﬁcient and the log of the IF (coefﬁcient: 0.13,
p < 0.001; adjusted R2 ¼ 0.26), with journals with
higher IFs having lower Gini coefﬁcients (Figure 1),
signifying that higher-impact journals have a more
equal distribution of citations compared with lower-
impact journals. After removing the highly-cited
documents, the Gini coefﬁcients of the top 3 IF jour-
nals decreased by 0.05, 0.01, and 0.03, respectively.
There is a relationship between more equal citation
distributions and higher IF cardiovascular journals.
Our ﬁndings reassure readers that IFs are generally
representative of the quality and contribution of the
entire spectrum of a journal’s papers and not just a
select few. Nevertheless, there was high variation
overall in citations.
Among the 3 highest-impact journals, there is
evidence of inequality. However, these journals’ Gini
coefﬁcients became more equal, to different degrees,
after removing high-citation documents, suggesting
that these papers have a marked impact on a given
journal’s citation distribution. A limitation of the
study is that factors other than citations may inﬂu-
ence the IF of a journal, particularly the deﬁnition of
citable documents. The Gini coefﬁcient is a useful
measure of citation inequalities.Sudhakar V. Nuti, BA
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Vulnerable Plaque and
Coronary Artery StenosisWith great interest I read the article by Tian et al. (1)
examining the relationship between angiographic
coronary stenosis and features of vulnerable plaque
(thin-cap ﬁbroatheroma [TCFA]) using optical coher-
ence tomography. The authors demonstrated that the
absolute number of TCFAs was greatest in group A
(angiographic diameter stenosis (DS): 30% to 49%,
n ¼ 58), followed by groups B (DS: 50% to 69%, n ¼
40) and C (DS: >70%, n ¼ 33). However, the absolute
number of TCFAs in group C may be underestimated
because “[a]fter treatment of the culprit/target lesion,
IVUS and OCT imaging were performed in all 3 coro-
nary arteries.” It is difﬁcult to determine TCFAs after
treatment. The culprit/target lesions are supposed
to have a DS >70% (group C), and some plaques of the
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1713culprit/target lesions could be TCFAs. Therefore, it
would be of great help if the authors could provide
the number of the culprit/target lesions in each
group.
In addition, the authors previously reported 58
TCFAs and 19 ruptured plaques in 184 nonculprit le-
sions in 82 patients with acute coronary syndrome (2).
Because the ruptured plaques resulted from TCFAs, I
would appreciate it if the authors could provide the
number of the ruptured plaques in each group,
although angiographic stenosis could change to some
degree after rupture. These data can help us to
completely understand the relationship between
vulnerable plaque and angiographic stenosis.FIGURE 1 Incidence of PPMI in the Presence of Factors Associated With an
Increased Risk of Ischemic Myocardial Injury During PCI
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Fibrinogen
An Independent Link Between Diabetes
Mellitus, Impaired On-Clopidogrel Platelet
Inhibition, and Major Adverse Cardiac Events
After Percutaneous Coronary Intervention0
All
Subjects
Result
PRU ≥230
Platelet
Inhibition <30%
Fibrinogen
≥345 mg/dl
Fibrinogen
≥345 mg/dl &
CRP ≤0.5 mg/dl
Subjects with baseline ﬁbrinogen level $345 mg/dl had a higher incidence of both CK-MB–
deﬁned PPMI (*controlled for platelet reactivity and inﬂammatory markers) and troponin
I/T–deﬁned PPMI (†controlled for age, platelet count, platelet reactivity, and inﬂammatory
markers) supported by multiple variable testing. Subjects with an elevated baseline
ﬁbrinogen level in the absence of systemic inﬂammation (CRP #0.5 mg/dl) had an even
higher incidence of CK-MB–deﬁned PPMI based on multiple variable interaction testing
(‡controlled for ﬁbrinogen and CRP), but a higher incidence of troponin I/T–deﬁned
PPMI was only supported by univariate analysis (§). *†‡Multiple variable regression
p value <0.05; §univariate p value <0.05. CK-MB ¼ creatine kinase-myocardial band;
CRP ¼ C-reactive protein; PPMI ¼ periprocedural myocardial infarction; PRU ¼ P2Y12
reactivity unit. Reproduced with permission from Ang et al. (4).We read with great interest the recent paper and
editorial written by Angiolillo et al. (1) and Price (2)
in the Journal regarding diminished platelet inhibi-
tion (PI) response to clopidogrel in diabetic patients
attributable to impaired metabolism of the clopi-
dogrel prodrug to its active metabolite in subjects
with stable coronary artery disease (CAD). As cited by
the authors, we previously identiﬁed an elevated
serum ﬁbrinogen level in diabetic patients undergo-
ing PCI to be associated with impaired on-clopidogrel
PI (3). Before interaction testing, decreased PI was
observed in the presence of diabetes mellitus (DM)
(34.4  23.0 vs. 47.4  28.7%; p ¼ 0.021) and
ﬁbrinogen $375 mg/dl (31.9  23.0 vs. 44.8  26.8%;p ¼ 0.047). After testing for interactions, elevated
ﬁbrinogen together with DM (p ¼ 0.026), indepen-
dent of either DM (p ¼ 0.457) or elevated ﬁbrinogen
(p ¼ 0.600) alone, remained signiﬁcantly associated
with lower PI.
After this observation, the following remained
unclear: 1) whether elevated ﬁbrinogen in diabetic
patients is simply a marker of greater systemic
inﬂammation or actively facilitates increased platelet
cross-linking as measured by in vitro platelet aggre-
gation testing, and 2) with an elevated ﬁbrinogen
level, is it impaired on-treatment PI or DM most
closely associated with the occurrence of major
adverse cardiac events (MACE) after PCI? Subse-
quently, we reported our ﬁndings in the Journal
that an elevated ﬁbrinogen level, independent of
platelet reactivity or DM, is associated with myo-
cardial infarction within 24 h after PCI (odds ratios:
ﬁbrinogen $345 mg/dl 4.75 [95% conﬁdence interval:
1.2 to 18.5]), whereas PI <30% or the presence of
DM is not associated (4) (Figure 1). In the subset of
subjects without systemic inﬂammation (C-reactive
